Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

12th World AIDS Conference

protease psychoanalytic 159

Keyword

Abstr

ant interferon-a-2B and inhibitors/Interferon-a-2B treatm
s/Cost-effectiveness of inhibitors/Cost-effectiveness of
spartyl proteinase/HIV inhibitors have a direct anti-Cand
nd HCV-RNA by use of inhibitors/No difference in HCV v
ed patients treated with inhibitors/HCV viral load in HCVbocytopenia/Effects of inhibitors in HIV-related thrombo
oviral therapy including inhibitors (PI)/Reversal of neutro
out-patients/Impact of inhibitor treatment on body comp
e in logio HIV RNA and inhibitor use associated with wei
iral treatment including inhibitors/Progressive multifocal
gnitive impairment with inhibitors based regimens/Regr
s who have failed prior inhibitors (PIs): A clinical cohort s
roject/Transmission of inhibitor resistant HIV-1 to a rece
nt mutations of the HIV gene were associated with thera
atients, following initial failure/Long-term viral suppressi
in HIV+ patients failing inhibitor-based highly active antir
and attitudes regarding inhibitors among HIV infected pa
ce program/Nationwide inhibitor adherence program/Na
edictors/Adherence to inhibitor (PI) therapy in clinical pr
ns for discontinuation of inhibitor treatment: A clinical sur
e on HIV+ patients and inhibitors/Adherence re-framed i
adherence to the use of inhibitors/Factors which influenc
a new non-peptidic HIV inhibitor, in a phase 1/11 study/Th
ed patients treated with inhibitors/Peripheral insulin resi
ected cells treated with inhibitors/Accumulation of gag-p
fected children with the inhibitor nelfinavir mesylate/Pre
busers/Methadone and inhibitors in HIV-infected drug ab
pe/High prevalence of resistance mutations in therapyatural polymorphism in coding region of seroconverters/
nce surmountable HIV inhibitor effective against both wi
ediction of response by genotyping/Nelfinavir in HAART
ar cells/Comparison of mutations in HIV-1 genomes det
e to nelfinavir/Impact of gene mutations on virological res
oss-resistance among inhibitors in over 1,000 clinical HI
ring equitable access to inhibitors/Ensuring equitable ac
ding affinity (ka) of HIV inhibitors to a-1 acid glycoprotei
vailability of a novel HIV inhibitor JE-2147 (KNI-764) in an
a/Methods to measure inhibitor (PI) and reverse transcri
ot currently receiving inhibitor therapy: Results from a
uring 1997/The use of inhibitors among HIV+ and AIDS
ccess to treatment with inhibitor (PI) containing regimen
A, 1997-98/Receipt of inhibitor therapy by street-recruit
I database/Patterns of inhibitor use by healthcare cover
dicaid recipients/Use of inhibitors in HIV+ Medicaid recipi
zil/Impact of the use of inhibitors in newly diagnosed Al
ed adults/The effect of inhibitors on the nutritional healt
els in patients receiving inhibitors in clinical practice: Res
ion therapies including inhibitors (PI): economical impac
on therapy containing a inhibitor/Serum lipids changes i
nfection, and the use of inhibitors/Diabets, HIV infection,
ociated with initiation of inhibitor therapy/Thromboembol
men/Factors related to inhibitor (PI) adherence among s
erse transcriptase and genotypes in patients with HIV-1
erapy for patients failing inhibitor based therapy/Nelfinavi
he age of 50/The use of inhibitors (PI) in HIV infected pati
ophilic patients/Natural mutations observed in HIV infect
o years experience with inhibitor (PI) use in a large clinica
ealth related goals/A inhibitor support group helps pati
s with increased use of inhibitors in HIV+ patients/Decre
s/Lack of activity of the inhibitors on the HCV replication
viduals/Chronic use of inhibitors is associated with hor
dverse reactions during inhibitors therapy/Adverse reacti
unological response to inhibitor therapy in HIV-infected
ed patients in the era of inhibitor therapy/Elderly HIV-inf
tion of the utilization of inhibitors in AIDS patients in a pu
ot study comparing two inhibitor (PI) regimens (d4T+3T
se in triple therapy with inhibitor (PI) in HIV infected patie
Virological response to inhibitor-containing regimens ac
Pharmacokinetics with inhibitors/Activity of TaxotereTM (
on of triple therapy with inhibitors (PI)/Comparison of vir
na in patients with HIV: Proteases pave path-bridging the gap bet
chools: "La comunidad protege a sus jovenes"/Linking sexual an
ells/mm3: CPCRA 038/ Protein intake is associated with body cell
between nucleocapsid protein, viral RNA and protease of HIV-1 o
athway/The HIV-1 Nef induces CD4+ T-cell apoptosis thr

main of SIVmac251 nef in the viral pathogenesis/Implicati
n monocytes/HIV-1 Tat promotes the synthesis of plateleticiency virus type 1 Nef quasi-species from long-term nonthe tumour suppressor p53 and inhibits apoptosis/HIV-1
otic apparatus (NuMA) by HIV-1 protease may play a role i

act23146
24125
31211
32111
32113
32138
32149
32177
32180
32194
32196
229*/32287
32288
32294
32295
32305
32316
32327
32337
32353
32365
32404
293*/41176
179*/41177
41184
41191
41202
41208
41210
555*/41212
41215
41217
41222
230*/42195
42226
42268
42273
42277
413*/42282
42300
42305
42309
42310
42314
42317
42346
42403
44247
60118
60148
60160
60192
60316
60365
60388
60444
60547
60574
60578
60598
60648
60658
60703
60704
60754
60791
60805
60812
60934
60992
42252
13528
42339

379*/11131
11145
11213
21141
21142
21148
21150

Keyword

Abstract

rophage inflammatory 1 a (MIP1 a) in mononuclear cells 21189
ion with a recombinant expressing the native V1/V2 doma 550*/21194
velope-based DNA and immunization strategies for broade 551*/21196
Role of mannon-biding (MBP) in infectious episodes in pe 31164
women/Effect of a high diet upon protein metabolism in HI 32166
esistance exercise and supplementation effect on lean bo 32185
agents to nucleocapsid zinc knuckles without affecting cell 41187
he HIV-1 nucleocapsid p7/An electrochemiluminescence 42129
tervention/Whole body turnover in HIV-infected patients, e 42332
ith HIV/AIDS/Low cost diet for people living with HIV/AIDS 60217
HEART)/Adherence to proteinase inhibitor based highly effective 12298
rt study/Introduction of inhibitors results in decreasing 22221
ion of Candida aspartyl /HIV protease inhibitors have a 31211
D4 and V3 loop binding proteins /The binding of HIV to permissive 11114
ystem of viral structural /The role of the cytoskeleton of HI 11137
alizations of HIV-1 Gag and formation of O-shaped virion 11138
T cell response to HIV-1 among HLA disparate North Ame 602*/31128
L) activity against HIV-1 is not associated with risk of deat 31155
hat binds cell-surface /Specific inhibition of T-lymphocy 41182
cting cellular zinc finger /Targeting anti-HIV agents to nuc 41187
virus type 1 activities of from 17 species of plants/Anti-hu 41203
exogenous Nef and Tat on HIV-1 infected or uninfected ly 60872
rcoma/Phase 2 study ( Protocol L1057-28) of PanretinTM capsules 22278
merican phase 3 study ( L1057T-31) of PanretinTM gel (LG 619*/22283
S Study Group GASG 022)/The impact of viral load (VL 22368
IV-associated wasting ( W-002)/Open label use of thalid 32170
bacavir (1592, ABC) in protocol CNAB 2002, provides effective, I 12212
a/Modified ACTG-076 and its initial results in the largest 12408
s incomplete 076 ACTG useful in reducing vertical HIV-1 t 32450
ive sample preparation /Linear range of Roche Amplicor 41146
biotechnology transfer (GARBTTP) to facilitate access t 42320
unction/Evaluation of a for the early diagnosis of HIV-rela 60697
HIV/AIDS drug therapy protocols and results/An internet databas 42240
hout the course of HIV/ Proton MR spectroscopy findings through 12125
d HIV dementia/In vivo proton MRS studies of HIV brain injury and 32204
ous system infection by prototheca wickerhamii in an HIV infected 32213
ew gag primers, and a prototype automated version to quantitate 41145
ntrolled evaluation of a informed consent process for HI 43544
ble contraceptive Depo Provera and integrity of the cervical epithel 23462
stopping therapy/Slow proviral DNA reduction in patients on triple 266*/11152
o not correlate with the sequence variability: Cross-sectio 11158
ads to minimal levels of DNA and to immune recovery/Su 12371
luding indinavir/HIV-1 DNA and plasma RNA changes in 41140
urvival/Comparison of DNA in HIV-1 and HIV-2 infected 41147
/Quantification of HIV-1 DNA/Quantification of HIV-1 42172
s/The change of HIV-1 DNA copy number in peripheral m 42174
serial samples of HIV-1 DNA from treated patients/LiPA e 42198
atients with psoriasis or pruritus treated with phototherapy/Alterat 32265
blic sex environments ( PSE ) in North West London/"Who's cruisin 13424
ublic sex environment ( )/An evaluation of community-based 43293
xposure prophylaxis ( PSEP ) with HAART after sexual assault/P 250*/33174
by a V3 loop mimicking pseudopeptide that binds cell-surface pro 41182
CD4+ T-cells/Effective pseudotyping of retroviral vectors with SI 41245
on in AIDS patients with psoriasis or pruritus treated with photothe 32265
serious mental illness/ Psychiatric diagnoses and symptomatolo 23531
ents with HIV infection/ disorders in patients with HIV i 24221
ients: Who, how, why?/ and psychological consultatio 60793
ption/Neurological and psychiatric disorders in HIV-positive indivi 12449
d sexuality workshop for in-patients/Health and sexuali 23556
ience/Changes in HIV network practice after 18 mont 24154
s and HIV/developing a mobil team: Experiences in th 24241
S patients/A high rate of comorbidity in South African H 32258
ccommodation in neuro institutions of psychiatric patie 44197
udes and behaviors and diagnosis/HIV-related attitud 60164
busers with and without comorbidity/Results of HIV pr 60380
nd condom use among psychiatrically diagnosed adolescents/H 60163
IDS Dementia and HIV Psychiatry Service (ADAHPS)/Meeting th 32429
alytic intervention in the psychic life of HIV-positive pregnant wom 24234
eat advantage in social psycho-medico support in Chad/The poly 60424
patients with HIV/AIDS/ Psycho-social reactions and coping strate 12455
V seropositive women/ profile in Indian HIV seropo 23482
mphasis on housing/ needs of people living with 44181
itive immigrant women/ care of HIV-positive immigr 60942
Is in Nairobi/Emerging psycho-social needs for HIV positive pers 33281
o African-Americans/A model for services to Africa 34204

idarite: an alternative to care/Point-Solidarite: an al 34248
AIDS (PLWHIV/AIDS)/ Psycho-spiritual counselling: An alternati 60537
their families/Christian psycho-spiritual strategies to handle HIV 60145
ctice and future action/ Psychoactive substance use among peop 13341
Some consequences of psychoanalytic intervention in the psychic 24234